My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Surgery Partners, Inc. - Common Stock (NQ:SGRY)

14.73 -0.04 (-0.27%)

Delayed Quote Updated: 10:48 AM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Surgery Partners, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

3 Profitable Stocks We’re Skeptical Of

Today 0:43 EDT

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

1 Russell 2000 Stock with Competitive Advantages and 2 Facing Headwinds

October 09, 2026

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...

Via StockStory

Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know

September 23, 2026

What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as the Centers for Medicare and Medicaid S...

Via StockStory

Surgery Partners (SGRY): Buy, Sell, or Hold Post Q2 Earnings?

September 23, 2026

Surgery Partners’s 30.8% return over the past six months has outpaced the S&P 500 by 12.8%, and its stock price has climbed to $15.67 per share. This was par...

Via StockStory

Topics Bankruptcy Stocks

Surgery Partners Inc (NASDAQ:SGRY) Q1 2026 Results Show Narrower Loss and Revenue Beat, But Stock Dips ↗

May 05, 2026

Via Chartmill

Surgery Partners Director Teresa DeLuca Buys 11,250 Shares ↗

September 03, 2026

As the stock price dips lower, this executive purchase shows confidence in the future of Surgery Partners.

Via The Motley Fool

Topics Regulatory Compliance

3 Cash-Producing Stocks Walking a Fine Line

August 27, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

Surgery Partners (SGRY) Q2 2026 Earnings Call Transcript ↗

August 17, 2026

Idaho Falls sale signals shift to pure-play surgical focus.

Via The Motley Fool

Topics Earnings

The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call

August 17, 2026

Surgery Partners’ second quarter results were received positively by the market, with management highlighting that revenue and adjusted EBITDA came in ahead ...

Via StockStory

Topics Earnings

1 of Wall Street’s Favorite Stocks to Research Further and 2 We Avoid

August 14, 2026

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Via StockStory

Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY)

August 12, 2026

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the outpatient & specialty care stocks, including Surgery Partners (NASDAQ:SGRY) and it...

Via StockStory

Topics Artificial Intelligence

SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift

August 11, 2026

Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 2.7% year on year to $848.9 million. Th...

Via StockStory

Surgery Partners Q2 Earnings Call Highlights ↗

August 10, 2026

Surgery Partners (NASDAQ:SGRY) reported second-quarter 2026 revenue and adjusted EBITDA above its internal expectations, while reaffirming its full-year outlook ahead of the anticipated sale of its...

Via MarketBeat

Topics Earnings

Surgery Partners (NASDAQ:SGRY) Beats Q2 CY2026 Sales Expectations

August 10, 2026

Healthcare company Surgery Partners (NASDAQ:SGRY) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 2.7% year on year to $...

Via StockStory

Surgery Partners (SGRY) Q2 Earnings: What To Expect

August 08, 2026

Healthcare company Surgery Partners (NASDAQ:SGRY) will be announcing earnings results this Monday before market hours. Here’s what to expect. Surgery Partner...

Via StockStory

Topics Artificial Intelligence

1 Profitable Stock for Long-Term Investors and 2 Facing Challenges

July 31, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

3 Russell 2000 Stocks We Steer Clear Of

July 29, 2026

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...

Via StockStory

1 Healthcare Stock to Target This Week and 2 We Brush Off

July 20, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...

Via StockStory

3 Stocks Under $50 with Warning Signs

July 10, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Via StockStory

1 Cash-Producing Stock Worth Your Attention and 2 We Find Risky

July 06, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

Why Surgery Partners (SGRY) Stock Is Trading Up Today

July 02, 2026

What Happened? Shares of healthcare company Surgery Partners (NASDAQ:SGRY) jumped 2.7% in the morning session after Cantor Fitzgerald reiterated its "Overwei...

Via StockStory

Unpacking Q1 Earnings: Surgery Partners (NASDAQ:SGRY) In The Context Of Other Outpatient & Specialty Care Stocks

June 18, 2026

Looking back on outpatient & specialty care stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Surgery Partners (NASDAQ:SGRY...

Via StockStory

Topics Artificial Intelligence

3 Reasons to Sell SGRY and 1 Stock to Buy Instead

June 16, 2026

Surgery Partners currently trades at $15.10 per share and has shown little upside over the past six months, posting a small loss of 2.7%. The stock also fell...

Via StockStory

Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026? ↗

June 10, 2026

Outpatient surgery giant or home-based respiratory care leader, which business model stands out as healthcare spending patterns evolve and margins diverge?

Via The Motley Fool

1 Small-Cap Stock to Keep an Eye On and 2 That Underwhelm

May 21, 2026

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...

Via StockStory

3 of Wall Street’s Favorite Stocks Walking a Fine Line

May 18, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...

Via StockStory

Topics Economy

5 Revealing Analyst Questions From Surgery Partners’s Q1 Earnings Call

May 12, 2026

Surgery Partners’ first quarter saw revenue growth above Wall Street expectations, with management attributing performance to stability across its surgical f...

Via StockStory

Topics Earnings

3 Healthcare Stocks Walking a Fine Line

May 07, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged...

Via StockStory

SGRY Q1 Deep Dive: Stable Margins and Physician Recruitment Offset Volume Headwinds

May 06, 2026

Healthcare company Surgery Partners (NASDAQ:SGRY) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 4.5% year on year to $8...

Via StockStory

Surgery Partners SGRY Q1 2026 Earnings Transcript ↗

May 05, 2026

Surgery Partners SGRY Q1 2026 Earnings Transcript

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.